Presentations Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Medicenna Therapeutics Corp. - Corporate Presentation Q3 2023 Past Events September 13, 2023 at 2:30 PM EDT H.C. Wainwright 25th Annual Global Investment Conference Go to August 9, 2023 at 8:30 AM EDT Medicenna Therapeutics Provides Clinical Update from Phase 1/2 ABILITY Study Go to July 20, 2023 National Brain Tumor Society's Research Round Table Go to April 25, 2023 at 3:30 PM EDT 2023 Bloom Burton & Co. Healthcare Investor Conference Go to April 14 - April 19, 2023 American Association for Cancer Research (AACR) Annual Meeting Go to March 14, 2023 at 2:40 PM EDT Oppenheimer 33rd Annual Healthcare Conference Go to Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
August 9, 2023 at 8:30 AM EDT Medicenna Therapeutics Provides Clinical Update from Phase 1/2 ABILITY Study Go to
